Highlights: Bellberry human research ethics committee approved the phase 1 clinical trial investigating safety and pharmacokinetics of IHL-675A on July 20, 2022 The trial will be performed at CMAX Clinical Research, a dedicated and experienced clinical trial centre in Australia, and managed by Avance Clinical The trial will assess the pharmacokinetics, safety, and tolerability of combination…


Previous articlePT340 – Joost Breeksema – The Interdisciplinary Conference on Psychedelic Research (ICPR) & The Patient Perspective
Next articleHAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants